Here’s the complete list of 14 instruments.
Your selected category will be highlighted. Some instruments will be highlighted more than once.
Includes a scoring and interpretation guide. Surveys the presence of symptoms of depression, using a validated diagnostic algorithm (PRIME-MD). Also probes for seasonal pattern of the symptoms and presence of atypical neurovegetative features. An interpretation guide is included for use by clinicians in patient pre-screening. Can be completed in the waiting room or sent to prospective patients.
With instruction and interpretation guide. The DIAD is a structured interview that allows the rater to assess atypical symptoms of depression based on both DSM-IV and Columbia criteria. This instrument was designed to ease questioning on the sensitive issue of rejection sensitivity and to increase the specificity and reliability of the diagnosis.
Contains scoring and interpretation guide, to help determine whether a clinical consultation for SAD is indicated.
The HIGH-C measures the pattern and severity of symptoms that characterize hyperthymia, hypomania, and mania. A subset of the items can be used to provide a provisional DSM-IV diagnosis of current Hypomanic Episode or lifetime Bipolar II disorder. Expands on the scope & DSM symptoms, for a more sensitive evaluation.
The original MEQ of Horne and Östberg revised for smooth presentation in American English, with substitution of categorical ratings and one scoring correction. As shown in the feedback section of the self-assessment version (below), the MEQ is used to gauge circadian rhythm phase based on estimated melatonin onset, and derive optimum timing for light therapy.
Contains DSM-IV scoring algorithm and interpretation guide. The HIGH-R provides a provisional lifetime diagnosis irrespective of current clinical state.
Contains score interpretation guide and circadian phase estimate for timing of light therapy.
Includes a combined instruction guide for the HIGH instruments. Especially useful for outpatient monitoring.
Designed for general use in depression research and clinical evaluation, regardless of seasonality. The questions have greater specificity those in the predecessor SIGH-SAD and the flow of questioning is distinctly smoother. The SIGH-ADS rates the severity of depressive symptoms in terms of Hamilton’s 17- and 21-item depression scales and the NIMH/Columbia addendum of eight atypical symptoms.
Self-Rating Version. A checklist adaptation of the comprehensive NIMH interview, used to detect and monitor side effects of light, negative air ion, or drug treatment.
Scoring algorithm generates detailed scale and symptom assessment for self-monitoring of current state or preparation for office visits.
A structured chart for, or whether ophthalmologists and optometrists to determine whether there are ocular contraindications for use of bright light therapy, or whether periodic monitoring is indicated.
Contains scoring and interpretation guide for clinicians. This version can be used as a stand-alone instrument for outpatient monitoring, or for reliability checks against interviewer ratings on the
SIGH-SAD (predecessor of the SIGH-ADS).
Contains scoring and interpretation guide for clinicians. This version can be used as a stand-alone instrument for outpatient monitoring, or for reliability checks against interviewer ratings on the SIGH-SAD (predecessor of the SIGH-ADS).